Session

IBD (Posters)

PATIENTS WITH CROHN'S DISEASE HAVE MORE PSYCHOPATHOLOGY THAN THE NORMATIVE POPULATION, BUT LESS THAN PSYCHIATRIC OUTPATIENTS
PATIENTS WITH CROHN'S DISEASE HAVE MORE PSYCHOPATHOLOGY THAN THE NORMATIVE POPULATION, BUT LESS THAN PSYCHIATRIC OUTPATIENTS

IBD (Posters)  et al.

EARLY BIOMARKERS OF RESPONSE TO FERRIC CARBOXYMALTOSE TREATMENT IN GASTROINTESTINAL-RELATED INFLAMMATORY AND NON-INFLAMMATORY IRON DEFICIENCY ANEMIA: A PRELIMINARY STUDY
EARLY BIOMARKERS OF RESPONSE TO FERRIC CARBOXYMALTOSE TREATMENT IN GASTROINTESTINAL-RELATED INFLAMMATORY AND NON-INFLAMMATORY IRON DEFICIENCY ANEMIA: A PRELIMINARY STUDY

IBD (Posters)  et al.

TOFACITINIB IN SEVERE STEROID RESISTANT ULCERATIVE COLITIS AS A RESCUE THERAPY
TOFACITINIB IN SEVERE STEROID RESISTANT ULCERATIVE COLITIS AS A RESCUE THERAPY

IBD (Posters)  et al.

USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY
USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY

IBD (Posters)  et al.

PREVALENCE OF ANTI-ANISAKIS SIMPLEX ANTIBODIES IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN NORWAY: CORRELATION WITH DISEASE PHENOTYPE AND CLINICAL ACTIVITY
PREVALENCE OF ANTI-ANISAKIS SIMPLEX ANTIBODIES IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN NORWAY: CORRELATION WITH DISEASE PHENOTYPE AND CLINICAL ACTIVITY

IBD (Posters)  et al.

MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU
MANAGEMENT OF PATIENTS NEWLY DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BASED ON HOSPITAL CHARACTERISTICS: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

IBD (Posters)  et al.

MACROPHAGES AS AN EMERGING SOURCE OF NOTCH LIGANDS: RELEVANCE IN CROHN´S DISEASE COMPLICATIONS
MACROPHAGES AS AN EMERGING SOURCE OF NOTCH LIGANDS: RELEVANCE IN CROHN´S DISEASE COMPLICATIONS

IBD (Posters)  et al.

ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY
ASSESSMENT OF THE NUTRITIONAL STATUS OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS ACCORDING TO DISEASE ACTIVITY

IBD (Posters)  et al.

IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE
IMPACT ON QUALITY OF LIFE OF SETON PLACING IN PERIANAL CROHN'S DISEASE

IBD (Posters)  et al.

VITAMIN D AND BONE MINERAL DISEASE IN INFLAMMATORY BOWEL DISEASE PATIENTS
VITAMIN D AND BONE MINERAL DISEASE IN INFLAMMATORY BOWEL DISEASE PATIENTS

IBD (Posters)  et al.

PREGNANCY COMPLICATIONS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A NATIONAL COHORT STUDY
PREGNANCY COMPLICATIONS IN WOMEN WITH INFLAMMATORY BOWEL DISEASE: A NATIONAL COHORT STUDY

IBD (Posters)  et al.

USE OF GASTRIC ACID SUPPRESSANTS AND RISK OF DISEASE ACTIVITY EXACERBATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
USE OF GASTRIC ACID SUPPRESSANTS AND RISK OF DISEASE ACTIVITY EXACERBATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

IBD (Posters)  et al.

INCIDENCE AND RISK FACTORS ASSOCIATED WITH RECURRENCE OF CROHN´S DISEASE AFTER DEFINITIVE PANPROCTOCOLECTOMY AND ILEOSTOMY: THE IFARPI STUDY
INCIDENCE AND RISK FACTORS ASSOCIATED WITH RECURRENCE OF CROHN´S DISEASE AFTER DEFINITIVE PANPROCTOCOLECTOMY AND ILEOSTOMY: THE IFARPI STUDY

IBD (Posters)  et al.

IMPROVED WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MESALAZINE IN ROUTINE CLINICAL PRACTICE IN THE NETHERLANDS: RESULTS FROM THE IMPACT STUDY
IMPROVED WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MESALAZINE IN ROUTINE CLINICAL PRACTICE IN THE NETHERLANDS: RESULTS FROM THE IMPACT STUDY

IBD (Posters)  et al.

MEDICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE DURING THE FIRST 12 MONTHS OF FOLLOW-UP IN PEDIATRIC, ADULT AND ELDERLY PATIENTS: A NORWEGIAN NATIONWIDE REGISTRY STUDY FROM 2009 TO 2016
MEDICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE DURING THE FIRST 12 MONTHS OF FOLLOW-UP IN PEDIATRIC, ADULT AND ELDERLY PATIENTS: A NORWEGIAN NATIONWIDE REGISTRY STUDY FROM 2009 TO 2016

IBD (Posters)  et al.

PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAïVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; INTERIM ANALYSIS
PERFUSE: A FRENCH PROSPECTIVE/RETROSPECTIVE NON-INTERVENTIONAL COHORT STUDY OF INFLIXIMAB-NAïVE AND TRANSITIONED PATIENTS RECEIVING INFLIXIMAB BIOSIMILAR SB2; INTERIM ANALYSIS

IBD (Posters)  et al.

USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN´S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL
USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN´S DISEASE: RESULTS FROM A WEEK 16 INTERIM ANALYSIS OF THE STARDUST TRIAL

IBD (Posters)  et al.

PHASE 2A PROOF OF CONCEPT PLACEBO CONTROLLED STUDY WITH ORAL ABX464 50MG QD IN ULCERATIVE COLITIS SHOWS ENDOSCOPIC IMPROVEMENT WITH LOSS OF MICROSCOPIC DISEASE ACTIVITY IN MOST ENDOSCOPIC RESPONDERS
PHASE 2A PROOF OF CONCEPT PLACEBO CONTROLLED STUDY WITH ORAL ABX464 50MG QD IN ULCERATIVE COLITIS SHOWS ENDOSCOPIC IMPROVEMENT WITH LOSS OF MICROSCOPIC DISEASE ACTIVITY IN MOST ENDOSCOPIC RESPONDERS

IBD (Posters)  et al.

INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS
INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS

IBD (Posters)  et al.

HIGH CORRELATION OF THE QUANTUM BLUE® RAPID ASSAY WITH HPLC TANDEM MASS SPECTROMETRY FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING
HIGH CORRELATION OF THE QUANTUM BLUE® RAPID ASSAY WITH HPLC TANDEM MASS SPECTROMETRY FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING

IBD (Posters)  et al.

Item 41 - 60 / 279
1 2
3
4 5 6 7 8 9 10 11 12 13 14